CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
66.78
+0.55 (0.83%)
May 7, 2025, 4:00 PM EDT - Market closed
CVS Health Revenue
CVS Health had revenue of $94.07B in the quarter ending March 31, 2025, with 6.92% growth. This brings the company's revenue in the last twelve months to $376.74B, up 4.75% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$376.74B
Revenue Growth
+4.75%
P/S Ratio
0.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
84.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Thermo Fisher Scientific | 42.90B |
CVS News
- 6 hours ago - Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance - CNBC
- 22 hours ago - Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks - Seeking Alpha
- 23 hours ago - Activist investor Glenview Capital reduces stake in CVS Health - Reuters
- 1 day ago - Glenview Capital Issues Statement on CVS Health - PRNewsWire
- 6 days ago - DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks - WSJ
- 6 days ago - CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment - Benzinga
- 6 days ago - CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone - Seeking Alpha
- 6 days ago - CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy - Seeking Alpha